Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Long-Term Engagement and Motivation Through Innovative Strategies in Adapted Physical Activity (IMPULSION)

12 maggio 2026 aggiornato da: Centre Hospitalier Universitaire de Nice

IMPULSION: Long-Term Engagement and Motivation Through Innovative Strategies in Adapted Physical Activity

Aging is associated with progressive declines in physical, functional, and psychosocial capacities, leading to reduced autonomy, increased risk of falls, chronic diseases, and decreased quality of life. Physical inactivity is a major aggravating factor, despite strong evidence that regular physical activity helps prevent age-related decline.

Adapted Physical Activity (APA) has demonstrated beneficial effects on physical function, mental health, pain, and healthcare utilization. However, long-term adherence to APA programs among older adults remains low, with fewer than 20% meeting World Health Organization recommendations. Therefore, innovative strategies are needed to improve sustained engagement in physical activity.

This multicenter, randomized, single-blind interventional study aims to compare the effectiveness of different APA strategies on long-term engagement in physical activity among adults aged 60 years and older.

A total of 600 participants will be randomized into four groups combining two key factors: (1) autonomy-based vs. non-autonomy-based approaches, and (2) classical APA vs. TEMPA-based APA programs. Each intervention consists of a 12-week program including 24 supervised sessions, with some groups incorporating a progressive transition toward autonomous practice.

The primary outcome is long-term physical activity engagement assessed using the QAPPA questionnaire at baseline, 6 months, and 12 months.

Secondary outcomes include:

Objective and self-reported physical activity levels (questionnaires and wearable devices) Functional capacities (muscle strength, endurance, gait speed, balance, cardiorespiratory fitness) Motivational and perceptual factors (e.g., enjoyment, fatigue, perceived effort, motivation) Quality of life (EQ-5D-5L) Biological markers (inflammatory, metabolic, metabolomic, and epigenetic profiles) to identify predictors of adherence and physiological response Cost-effectiveness and cost-utility analyses (incremental cost-effectiveness ratio)

Statistical analyses will be conducted using mixed linear models for repeated measures to evaluate time, group, and interaction effects. Additional analyses will include descriptive statistics, group comparisons, longitudinal trends, and economic evaluations.

This study aims to identify effective and sustainable APA strategies to improve long-term physical activity engagement and inform public health policies for older adults.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

600

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

      • Nice, Francia
        • CHU de Nice - Hopital de Cimiez
        • Contatto:
        • Contatto:
        • Investigatore principale:
          • Olivier GUERIN, Professor

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • Age 60 or older
  • Affiliation with, or beneficiary of, a social security system
  • No objection to the study

Exclusion Criteria:

  • Neurocognitive disorder preventing the provision of informed consent (MOCA <18)
  • Individuals under legal protection
  • Individuals deprived of liberty
  • Presence of a physical or cognitive condition preventing participation in the adapted physical activity protocol over 3 months:
  • Neurocognitive disorder (MOCA <18)
  • Neurodegenerative disease with severe symptoms preventing participation in the protocol
  • Neuromuscular disease with severe symptoms preventing participation in the protocol
  • Severe sensory impairments (blindness or profound deafness)
  • Amputation of one or more limbs
  • Non-independent mobility

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: group A
autonomy arm and classical practice
All participants in Group A will receive a total of 24 Adapted Physical Activity (APA) sessions delivered by a qualified APA professional over a 15-week period. Two sessions per week will be provided during the first 9 weeks. From week 10 to week 15, only one supervised in-person session per week will be offered, and participants will be asked to complete the second session independently. This transition in session planning is expected to promote more sustainable long-term engagement in physical activity, Each session will consist of a warm-up (approximately 10-15 minutes), a main exercise phase (including endurance, strength, balance, flexibility, and coordination exercises), and a cool-down period. The structure of the sessions will be consistent and will comply with physical activity prescription guidelines for older adults
Sperimentale: group B
autonomy arm and TEMPA practice

In Group B, sessions will more explicitly incorporate effort minimization strategies (TEMPA), which will be clearly communicated to participants. These strategies include encouraging focus on perceived enjoyment during exercise, allowing participants to choose music, involving participants in leading warm-ups, integrating game-based activities (e.g., dodgeball-type games), strengthening group cohesion and sense of affiliation, and providing individualized feedback on performance during sessions.

To ensure proper implementation, the instructor will receive specific training in the TEMPA theoretical model and its associated adaptations. The instructor will also be required to explicitly communicate the strategies used during sessions. A report documenting the strategies implemented will be completed by the instructor after each session

Sperimentale: group C
non-autonomy arm and classical practice
All participants in Group C will receive a total of 24 Adapted Physical Activity (APA) sessions delivered by a qualified APA professional over a 12-week period. Participants will attend two APA sessions per week.
Sperimentale: group D
non-autonomy arm and TEMPA practice
In Group D, sessions will more explicitly incorporate effort minimization strategies (TEMPA), which will be clearly communicated to participants. These strategies include encouraging participants to focus on perceived enjoyment during exercise, allowing them to choose music, involving them in leading the warm-up, integrating game-based activities (e.g., dodgeball-type games), strengthening group cohesion and sense of affiliation, and providing individualized feedback on performance during sessions.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
effectiveness of different Adapted Physical Activity (APA) programs
Lasso di tempo: at 12 months

The primary objective of this study is to compare the effectiveness of different Adapted Physical Activity (APA) programs on long-term engagement in physical activity among older adults.

Long-term engagement will be assessed through the level of physical activity, measured using the QAPPA questionnaire The Physical Activity Questionnaire for Older Adults (QAPPA) is a tool for measuring the physical activity of people aged 60 and over. It was developed to meet the objective of assessing the level of physical activity of older adults, taking into account their age and health.

at 12 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Analyze functional outcomes: strength
Lasso di tempo: at 3 months, and 6 months and 12 months
Strength: time to complete the Five Sit-to-Stand test
at 3 months, and 6 months and 12 months
perceptual and motivational factors of engagement
Lasso di tempo: at base line and at 3 months
EMAPS questionnaires: The Motivation Scale for Physical Activity for Health Purposes (EMAPS) is a tool that assesses individuals' motivations and engagement in physical activity. It measures intrinsic and extrinsic motivation, based on 7 main constructs: achievement, knowledge and stimulation, external, introjected and identified regulations, and amotivation. The scale includes 28 statements, each measured on a 1 to 7-point scale, thus allowing a precise assessment of participants' motivations.
at base line and at 3 months
perceptual and motivational factors of engagement
Lasso di tempo: at base line and at 3 months
PES questionnaire: The Physical Effort Scale (PES) is a tool designed to measure the approach and avoidance tendencies towards physical effort. It is used to understand the engagement in physical activity. The scale consists of two factors: approach and avoidance, with each factor having a high internal consistency. The PES-FR has been shown to be valid for measuring individual differences in physical effort evaluation and has implications for promoting physical activity.
at base line and at 3 months
perceptual and motivational factors of engagement
Lasso di tempo: at baseline and at 3 months
PANES questionnaire: PANES is a 17-item, self-administered questionnaire that assesses environmental factors in physical activity participation, such as neighborhood safety, aesthetic qualities, neighborhood infrastructure, and access to destinations
at baseline and at 3 months
Analyze functional outcomes: Muscular endurance
Lasso di tempo: at 3 months, and 6 months and 12 months
Muscular endurance: time to complete the One-Minute Sit-to-Stand test
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Gait analysis
Lasso di tempo: at 3 months, and 6 months and 12 months
Gait analysis: walking speed over 10 meters
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Balance
Lasso di tempo: at 3 months, and 6 months and 12 months
Balance: stabilometric measurements
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Body composition
Lasso di tempo: at 3 months, and 6 months and 12 months
Body composition: bioelectrical impedance analysis
at 3 months, and 6 months and 12 months
Analyze functional outcomes: Cardiorespiratory endurance
Lasso di tempo: at 3 months, and 6 months and 12 months
Cardiorespiratory endurance: VO₂ max and Harvard index assessed via the Harvard Step Test
at 3 months, and 6 months and 12 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

1 settembre 2031

Completamento dello studio (Stimato)

1 settembre 2031

Date di iscrizione allo studio

Primo inviato

5 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

12 maggio 2026

Primo Inserito (Effettivo)

19 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

19 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

12 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 25-PP-27

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi